UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000060240
Receipt number R000067789
Scientific Title Acute-phase sensorimotor deficits and unilateral spatial neglect after right-hemisphere stroke: an exploratory single-center observational study
Date of disclosure of the study information 2025/12/30
Last modified on 2025/12/30 23:25:19

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Acute-phase sensorimotor deficits and unilateral spatial neglect after right-hemisphere stroke

Acronym

Acute-phase sensorimotor deficits and unilateral spatial neglect after right-hemisphere stroke

Scientific Title

Acute-phase sensorimotor deficits and unilateral spatial neglect after right-hemisphere stroke: an exploratory single-center observational study

Scientific Title:Acronym

Acute-phase sensorimotor deficits and unilateral spatial neglect after right-hemisphere stroke: an exploratory single-center observational study

Region

Japan


Condition

Condition

stroke

Classification by specialty

Neurology Neurosurgery Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Compare somatosensory and motor functions between patients with and without USN after acute right-hemisphere stroke.

Basic objectives2

Others

Basic objectives -Others

Explore whether somatosensory function or spatiotemporal attention-assessed with a PC-based system-differed between high- and low-motor subgroups of patients with USN.

Trial characteristics_1

Exploratory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

somatosensory (multimodal somatosensory impairment)

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) a first-ever intracerebral hemorrhage or cerebral infarction in the right hemisphere; (2) age of 20 years or older; and (3) evaluation performed within 10 days after onset.

Key exclusion criteria

(1) prior history of stroke; (2) positive for coronavirus disease 2019; (3) presence of medical complications (e.g., pneumonia, urinary tract infection); (4) upper extremity orthopedic disorders; (5) inability to undergo evaluation due to infection control measures; and (6) inability to sit in a wheelchair.

Target sample size

122


Research contact person

Name of lead principal investigator

1st name Megumi
Middle name
Last name Shimodozono

Organization

Kagoshima University Graduate School of Medical and Dental Sciences

Division name

Department of Rehabilitation and Physical Medicine

Zip code

890-8520

Address

8-35-1, Sakuragaoka, Kagoshima city, Kagoshima

TEL

099-275-5339

Email

k8877352@kadai.jp


Public contact

Name of contact person

1st name Takashi
Middle name
Last name Hoei

Organization

Kagoshima univercity hospital

Division name

Division of rehabilitation

Zip code

890-0075

Address

8-35-1, Sakuragaoka, Kagoshima city, Kagoshima

TEL

099-275-5111

Homepage URL


Email

k8877352@kadai.jp


Sponsor or person

Institute

Kagoshima univercity

Institute

Department

Personal name



Funding Source

Organization

Japan Science and Technology Agency

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kagoshima univercity hospital

Address

8-35-1 sakuragaoka, kagoshima city

Tel

099-275-6624

Email

crmc@m2.kufm.kagoshima-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 12 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2024 Year 03 Month 01 Day

Date of IRB

2023 Year 03 Month 24 Day

Anticipated trial start date

2024 Year 03 Month 19 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Analysis in progress


Management information

Registered date

2025 Year 12 Month 30 Day

Last modified on

2025 Year 12 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067789